Cambridge, Mass., USA - September 22, 2015, Cambridge, Mass., USA - SAGE Therapeutics, a biopharmaceutical company, announced top managers promotions and appointments.
Article continues below
Anne Marie Cook joins SAGE as Senior Vice President, General Counsel
Ms. Cook was most recently with Aegerion Pharmaceuticals, where she served as Senior Vice President, General Counsel and Secretary. Before that, she was a partner with Boston-based law firm Choate Hall & Stewart.
Prior to joining Choate, Ms. Cook was Senior Vice President, Business & Corporate Development, General Counsel at ViaCell, Inc., and Chief Corporate Counsel at Biogen. Ms. Cook received her J.D. from the University of Notre Dame Law School and her B.S. in biology from Tufts University.
Jim Doherty, Ph.D., is promoted to Senior Vice President of Research
Dr. Doherty joined SAGE in 2012 and most recently served as Vice President of Pharmacology, Head of Biology. Before SAGE, he served as Director and Head of the Neuroscience Department for the CNS and Pain Innovative Medicine Unit of AstraZeneca Pharmaceuticals in Sodertalje, Sweden, and prior to that, he was Director and Head of the Neuroscience Department at AstraZeneca Pharmaceuticals in Wilmington, Del.
Dr. Doherty has authored more than 30 peer-reviewed research and review articles. He holds a B.A. in biology from the University of Delaware and a Ph.D. in neuroscience from Georgetown University. He was a postdoctoral fellow at Emory University Medical School.
Heinrich Schlieker, Ph.D., joins SAGE as Senior Vice President of Technical Operations
Dr. Schlieker joins SAGE from Cubist Inc., where he served as Vice President, Process Development & Manufacturing. Prior to his 10-year tenure at Cubist, he held various positions in process development and manufacturing support at Hoffman-La Roche in Switzerland, New Jersey and Germany.
Dr. Schlieker holds a Ph.D. in biochemical engineering and a chemistry degree from the Braunschweig University of Technology in Germany.
Ryan Arnold, D.O., joins SAGE as Vice President of Medical Affairs
Dr. Arnold comes to SAGE from Biogen, where he most recently served as Senior Director, Medical Affairs and Head, U.S. MSLs. ■